A carregar...
Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy
Treatment with anti‐programmed cell death protein 1 (PD‐1) antibodies has demonstrated clinical efficacy in a whole range of malignancies including advanced melanoma, renal cell cancer, bladder cancer, and non‐small cell lung cancer. Immune‐related adverse events are a unique side effect of checkpoi...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058335/ https://ncbi.nlm.nih.gov/pubmed/29666298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0531 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|